Avid Bioservices (NASDAQ:CDMO) Upgraded to “Sell” by StockNews.com

StockNews.com upgraded shares of Avid Bioservices (NASDAQ:CDMO – Free Report) to a sell rating in a report issued on Tuesday. Other research analysts also recently issued research reports about the company. Royal Bank of Canada boosted their target price on Avid Bioservices from $8.00 to $12.00 and gave the stock an outperform rating in a […]

Leave a Reply

Your email address will not be published.

Previous post Christmas food supplies at risk as new eu border rules threaten chaos, logistics leaders warn
Next post Deutsche Bank Aktiengesellschaft Raises Hershey (NYSE:HSY) Price Target to $199.00